STING1 and melanoma: To evaluate the STING pathway activation by the cGAMP-siPDL1@GalNPs, the B16F10 melanoma tumors were harvested at 8 hours after administration of the nanocarriers and analyzed by WB and quantitative polymerase chain reaction (qPCR).